Federated Hermes’s PDS Biotechnology PDSB Stock Holding History

Federated Hermes’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-123	Closed	-$756	–	2192
2023 Q1	$756	Sell	123 -163	-57%	-$1.33K	﹤0.01%	2057
2022 Q4	$3.77K	Sell	286 -749	-72%	-$5.28K	﹤0.01%	1954
2022 Q3	$3K	Buy	+1,035	New	+$4.39K	﹤0.01%	1940
2022 Q1	–	Sell	-93	Closed	-$1K	–	2279
2021 Q4	$1K	Sell	93 -484	-84%	-$5.21K	﹤0.01%	2138
2021 Q3	$9K	Buy	577 +469	+434%	+$5.85K	﹤0.01%	1994
2021 Q2	$1K	Buy	+108	New	+$843	﹤0.01%	2150
2021 Q1	–	Sell	-384,000	Closed	-$822K	–	2325
2020 Q4	$822K	Hold	384,000	–	–	﹤0.01%	1391
2020 Q3	$895K	Hold	384,000	–	–	﹤0.01%	1279
2020 Q2	$772K	Hold	384,000	–	–	﹤0.01%	1342
2020 Q1	$280K	Buy	+384,000	New	+$665K	﹤0.01%	1518

Other funds holding PDSB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Federated Hermes's PDSB Position: Q2 2023 in Review

Federated Hermes sold out of PDS Biotechnology (PDSB) in Q2 2023, closing a stake of 123 shares — an estimated $756 sold.

Federated Hermes first reported a position in PDSB in Q1 2020 and held it in 10 quarters. The position peaked at $895K in Q3 2020. 80 funds tracked by Wall St. Rank hold PDSB as of Q2 2023.

Federated Hermes reported no remaining PDS Biotechnology position as of Q2 2023 after selling out during the quarter.
Federated Hermes sold 123 PDS Biotechnology shares in Q2 2023, an estimated $756.
Federated Hermes first reported a position in PDS Biotechnology in Q1 2020 and held it in 10 quarters.
Federated Hermes's PDS Biotechnology position peaked at $895K in Q3 2020.
80 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2023.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.